REQUEST A DEMO
Total
USD $0.00
Search more companies

Boston Scientific International Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | All Other Support Services
Full name: Boston Scientific International Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Boston Scientific International Sdn. Bhd. is a company in Malaysia, with a head office in Simpang Ampat. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on January 22, 2021. In 2024, the company reported a net sales revenue increase of 52.31%. Over the same period, its total assets grew by 30.61%. In 2024, Boston Scientific International Sdn. Bhd.’s net profit margin decreased by 0.83%.

Headquarters
Pmt 741, Persiaran Cassia Selatan 1, Taman Perindusytian Batu Kawan
Simpang Ampat; Penang; Postal Code: 14110

Contact Details: Purchase the Boston Scientific International Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Boston Scientific International Sdn. Bhd. report to view the information.
Incorporation Date:
January 22, 2021
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
EXECUTIVE
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Boston Scientific International Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
52.31%
Total Operating Revenue
52.31%
Operating Profit
16.68%
EBITDA
8.09%
Net Profit/Loss for the Period
43.4%
Total Assets
30.61%
Total Equity
51.02%
Operating Profit Margin
-4.26%
Net Profit Margin
-0.83%
Return on Equity (ROE)
-1.93%
Quick Ratio
0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?